Searched for: in-biosketch:true
person:bredem02
Well-being grants in an academic medical center: A case example
Olson, Lauren E; Bredella, Miriam A; Levy, Anne S; Mehta, Darshan H
Academic medical centers (AMCs) rely on engaged and motivated faculty for their success. Significant burnout among clinical and research faculty has resulted in career disengagement and turnover. As such, AMCs must be vested in cultivating faculty engagement and well-being through novel initiatives that support faculty. The Well-Being Education Grants program was established by the Office for Well-Being within the Center for Faculty Development at Massachusetts General Hospital to provide the impetus many faculty needed to dedicate time to their well-being, demonstrating that investments in multi-component interventions around faculty well-being require resources and funding.
PMCID:10603360
PMID: 37900355
ISSN: 2059-8661
CID: 5736402
What is well-being? A scoping review of the conceptual and operational definitions of occupational well-being
Bautista, Tara G; Roman, Gretchen; Khan, Munziba; Lee, Michele; Sahbaz, Sumeyra; Duthely, Lunthita M; Knippenberg, Alexa; Macias-Burgos, Miracle A; Davidson, Alec; Scaramutti, Carolina; Gabrilove, Janice; Pusek, Susan; Mehta, Darshan; Bredella, Miriam A
Well-being is a multifaceted construct that is used across disciplines to portray a state of wellness, health, and happiness. While aspects of well-being seem universal, how it is depicted in the literature has substantial variation. The aim of this scoping review was to identify conceptual and operational definitions of well-being within the field of occupational health. Broad search terms were used related to well-being and scale/assessment. Inclusion criteria were (1) peer-reviewed articles, (2) published in English, (3) included a measure of well-being in the methods and results section of the article, and (4) empirical paper. The searches resulted in 4394 articles, 3733 articles were excluded by reading the abstract, 661 articles received a full review, and 273 articles were excluded after a full review, leaving 388 articles that met our inclusion criteria and were used to extract well-being assessment information. Many studies did not define well-being or link their conceptual definition to the operational assessment tool being used. There were 158 assessments of well-being represented across studies. Results highlight the lack of a consistent definitions of well-being and standardized measurements.
PMCID:10643923
PMID: 38028344
ISSN: 2059-8661
CID: 5617302
Breast adipose tissue attenuation as a novel imaging biomarker for cardiometabolic risk
Bunnell, Katherine M; Galdamez, Marilyn E; Torriani, Martin; Bredella, Miriam A
BACKGROUND:Certain adipose tissue depots infer higher cardiometabolic risk than body mass index (BMI). PURPOSE/OBJECTIVE:To assess breast adipose tissue (BrAT) attenuation as a novel imaging biomarker for cardiometabolic risk. MATERIAL AND METHODS/METHODS:We studied 151 women (mean age = 56 ± 1 years) across the weight spectrum. BrAT attenuation, abdominal adipose tissue cross-sectional areas (CSA), and attenuation were quantified using non-contrast computed tomography (CT) scans. Cardiometabolic risk factors were assessed from medical records. RESULTS: < 0.001). BrAT attenuation had a sensitivity of 90% but a specificity of only 35% in detecting the metabolic syndrome (area under the curve = 0.63). CONCLUSION/CONCLUSIONS:BrAT attenuation is associated with cardiometabolic risk markers and could serve as an imaging biomarker for opportunistic risk assessment in patients undergoing CT examination of the chest.
PMID: 36560894
ISSN: 1600-0455
CID: 5602142
Bone marrow adipose tissue is associated with fracture history in anorexia nervosa
Dang, T; Faje, A T; Meenaghan, E; Bredella, M A; Bouxsein, M L; Klibanski, A; Fazeli, P K
UNLABELLED:Although bone mineral density (BMD) is decreased and fracture risk increased in anorexia nervosa, BMD does not predict fracture history in this disorder. We assessed BMD, bone microarchitecture, and bone marrow adipose tissue (BMAT) in women with anorexia nervosa and found that only BMAT was associated with fracture history. INTRODUCTION/BACKGROUND:Anorexia nervosa (AN) is a psychiatric disorder characterized by low body weight, low BMD, and increased risk of fracture. Although BMD is reduced and fracture risk elevated, BMD as assessed by DXA does not distinguish between individuals with versus those without prior history of fracture in AN. Despite having decreased peripheral adipose tissue stores, individuals with AN have enhanced bone marrow adipose tissue (BMAT), which is inversely associated with BMD. Whether increased BMAT is associated with fracture in AN is not known. METHODS:H-MRS, and parameters of bone microarchitecture by HR-pQCT. RESULTS:Sixteen women (47.1%) with AN reported prior history of fracture compared to 11 normal-weight women (39.3%, p = 0.54). In the entire group and also the subset of women with AN, there were no significant differences in BMD or parameters of bone microarchitecture in women with prior fracture versus those without. In contrast, women with AN with prior fracture had greater BMAT at the spine and femur compared to those without (p = 0.01 for both). CONCLUSION/CONCLUSIONS:In contrast to BMD and parameters of bone microarchitecture, BMAT is able to distinguish between women with AN with prior fracture compared to those without. Prospective studies will be necessary to understand BMAT's potential pathophysiologic role in the increased fracture risk in AN.
PMCID:9940017
PMID: 35999286
ISSN: 1433-2965
CID: 5602602
Management of Neurofibromatosis Type 1-Associated Plexiform Neurofibromas
Fisher, Michael J; Blakeley, Jaishri O; Weiss, Brian D; Dombi, Eva; Ahlawat, Shivani; Akshintala, Srivandana; Belzberg, Allan J; Bornhorst, Miriam; Bredella, Miriam A; Cai, Wenli; Ferner, Rosalie E; Gross, Andrea M; Harris, Gordon J; Listernick, Robert; Ly, Ina; Martin, Staci; Mautner, Victor-F; Salamon, Johannes M; Salerno, Kilian E; Spinner, Robert J; Staedtke, Verena; Ullrich, Nicole J; Upadhyaya, Meena; Wolters, Pamela L; Yohay, Kaleb; Widemann, Brigitte C
Plexiform Neurofibromas (PN) are a common manifestation of the genetic disorder neurofibromatosis type 1 (NF1). These benign nerve sheath tumors often cause significant morbidity, with treatment options limited historically to surgery. There have been tremendous advances over the past two decades in our understanding of PN, and the recent regulatory approvals of the MEK inhibitor selumetinib are reshaping the landscape for PN management. At present, there is no agreed upon PN definition, diagnostic evaluation, surveillance strategy, or clear indications for when to initiate treatment and selection of treatment modality. In this review, we address these questions via consensus recommendations from a panel of multi-disciplinary NF1 experts.
PMID: 35657359
ISSN: 1523-5866
CID: 5283582
Load-to-strength ratio at the radius is higher in adolescent and young adult females with obesity compared to normal-weight controls
Singhal, Vibha; Huynh, Carolyn; Nimmala, Supritha; Mitchell, Deborah M; Pedreira, Clarissa C; Bader, Abeer; Flanders, Karen; Zheng, Jane; Bouxsein, Mary L; Misra, Madhusmita; Bredella, Miriam A
BACKGROUND:Among adolescents with extremity fractures, individuals with obesity have greater representation compared with individuals of normal-weight, despite having higher areal and volumetric bone mineral density (aBMD, vBMD) than their normal-weight counterparts. The relative increase in BMD in individuals with obesity may thus be insufficient to support the greater force generated upon falling. The load-to-strength ratio is a biomechanical approach for assessing the risk of fracture by comparing applied force to bone strength, with higher load-to-strength ratios indicating higher fracture risk. OBJECTIVE:To assess the load-to-strength ratio at the distal radius in adolescent and young adult females with severe obesity (OB) compared with normal-weight healthy controls (HC). We hypothesized that OB have a higher load-to-strength ratio compared to HC. METHODS:We examined bone parameters in 65 girls 14-21 years old: 33 OB and 32 HC. We used dual-energy X-ray absorptiometry (DXA) to assess body composition, high resolution peripheral quantitative CT (HR-pQCT) to estimate vBMD, and microfinite element analysis (μFEA) to assess bone strength at the distal radius. To quantify fracture risk, we computed the load-to-strength ratio, where the numerator is defined as the load applied to the outstretched hand during a forward fall and the denominator is the bone strength, as estimated by μFEA. RESULTS:, p = 0.002), load-to-strength ratio at the radius was greater in OB than HC after controlling for age and race (0.66 vs. 0.54, p < 0.0001). In OB, impact force and load-to-strength ratio were associated negatively with % lean mass (r = -0.49; p = 0.003 and r = -0.65; p < 0.0001 respectively) and positively with visceral fat (r = 0.65; p < 0.0001 and r = 0.36; p = 0.04 respectively). CONCLUSIONS:Adolescent and young adult females with obesity have higher load-to-strength ratio at the distal radius due to higher forces applied to bone in a fall combined with incomplete adaptation of bone to increasing body weight. This is differentially affected by lean mass, fat mass, and visceral fat mass.
PMCID:9826712
PMID: 35948256
ISSN: 1873-2763
CID: 5602022
A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods
Wronski, Marie-Louis; Plessow, Franziska; Kerem, Liya; Asanza, Elisa; O'Donoghue, Michelle L; Stanford, Fatima C; Bredella, Miriam A; Torriani, Martin; Soukas, Alexander A; Kheterpal, Arvin; Eddy, Kamryn T; Holmes, Tara M; Deckersbach, Thilo; Vangel, Mark; Holsen, Laura M; Lawson, Elizabeth A
BACKGROUND:Obesity affects more than one-third of adults in the U.S., and effective treatment options are urgently needed. Oxytocin administration induces weight loss in animal models of obesity via effects on caloric intake, energy expenditure, and fat metabolism. We study intranasal oxytocin, an investigational drug shown to reduce caloric intake in humans, as a potential novel treatment for obesity. METHODS:). We investigate the efficacy, safety, and mechanisms of oxytocin administration in reducing body weight. Secondary endpoints include changes in resting energy expenditure, body composition, caloric intake, metabolic profile, and brain activation via functional magnetic resonance imaging in response to food images and during an impulse control task. Safety and tolerability (e.g., review of adverse events, vital signs, electrocardiogram, comprehensive metabolic panel) are assessed throughout the study and six weeks after treatment completion. RESULTS:). The study sample is diverse with 38% identifying as non-White and 20% Hispanic. CONCLUSION:Investigating intranasal oxytocin's efficacy, safety, and mechanisms as an anti-obesity medication will advance the search for optimal treatment strategies for obesity and its associated severe sequelae.
PMCID:10329413
PMID: 36087842
ISSN: 1559-2030
CID: 5602062
The Virtual CTSA Visiting Scholar Program to Support Early-Stage Clinical and Translational Researchers: Implementation and Outcomes
Bredella, Miriam A; Rubio, Doris M; Attia, Jacqueline; Kelly, Thomas H; McIntosh, Scott; Meagher, Emma A; Pusek, Susan; Rubio, Mercedes; Tsevat, Joel; Umans, Jason G
In addition to restrictions on conducting research, COVID-19-related travel bans and scientific meeting cancellations have negatively affected scholars in the Clinical and Translational Science Award (CTSA) Mentored Career Development Award (KL2) program. In response, a national virtual visiting scholar program was developed to provide opportunity for KL2 scholars to be virtual visiting professors at another CTSA hub, meet faculty and scholars, and expand networks and build collaborations. This article describes the design and short-term outcomes of the virtual CTSA Visiting Scholar Program. In 2020, a working group designed core program elements and developed an application and selection process. Anonymized surveys were sent to scholars post visit and to scholars and program directors 6 months post visit to evaluate their experience and solicit suggestions for improvements. Between November 2020 and May 2021, 56 KL2 scholars and 27 hubs participated. Forty-five (80.4%) participating scholars responded to the initial survey. Nearly all scholars (44, 97.7%) agreed their experience was valuable. All respondents indicated they would recommend the program to other KL2 scholars. For the 6-month survey, the response rate was 87.5% (49/56). Within 6 months of their visit, 36 (73.5%) respondents had contacted at least one person at the host hub and for 17 (34.7%) respondents, new collaborations with the host hub ensued. Twenty-five of 27 (92.6%) host hubs responded to the survey. Most (21, 84.0%) agreed that hearing visiting scholar talks was valuable to their own scholars and 23 (92%) indicated likelihood of their hub participating in future round of the program. The virtual Visiting Scholar Program provided KL2 scholars an opportunity to virtually visit another CTSA hub, present their research, and meet with faculty and other scholars to expand their networks. Although geared to KL2 scholars, this model is potentially generalizable to other nationally coordinated career development programs.
PMID: 35263302
ISSN: 1938-808x
CID: 5602002
Reply to the letter to editor regarding, "Body composition predictors of mortality on computed tomography in patients with spinal metastases undergoing surgical treatment" [Comment]
Bongers, Michiel E R; Groot, Olivier Q; Buckless, Colleen G; Kapoor, Neal D; Twining, Peter K; Schwab, Joseph H; Torriani, Martin; Bredella, Miriam A
PMID: 35988948
ISSN: 1878-1632
CID: 5602032
The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity
Dichtel, Laura E; Corey, Kathleen E; Haines, Melanie S; Chicote, Mark L; Kimball, Allison; Colling, Caitlin; Simon, Tracey G; Long, Michelle T; Husseini, Jad; Bredella, Miriam A; Miller, Karen K
CONTEXT:Obesity is a state of relative growth hormone (GH) deficiency, and GH has been identified as a candidate disease-modifying target in nonalcoholic fatty liver disease (NAFLD) because of its lipolytic and anti-inflammatory properties. However, the GH/IGF-1 axis has not been well characterized in NAFLD. OBJECTIVE:We aimed to investigate serum GH and IGF-1 levels in relation to intrahepatic lipid content (IHL) and markers of hepatocellular damage and fibrosis in NAFLD. METHODS:This cross-sectional study included 102 adults (43% women; age 19-67; BMI ≥ 25 kg/m2) without type 2 diabetes. IHL was measured by magnetic resonance spectroscopy; NAFLD was defined by ≥ 5% IHL. Peak-stimulated GH in response to GH releasing hormone and arginine was assessed as was serum IGF-1 (LC/MS). RESULTS:There was no difference in mean age, BMI, or sex distribution in NAFLD vs controls. Mean (± SD) IHL was higher in NAFLD vs controls (21.8 ± 13.3% vs 2.9 ± 1.1%, P < 0.0001). Mean peak-stimulated GH was lower in NAFLD vs controls (9.0 ± 6.3 vs 15.4 ± 11.2 ng/mL, P = 0.003), including after controlling for age, sex, visceral adipose tissue, and fasting glucose. In a stepwise model, peak-stimulated GH predicted 14.6% of the variability in IHL (P = 0.004). Higher peak-stimulated GH was also associated with lower ALT. Higher serum IGF-1 levels were associated with lower risk of liver fibrosis by Fibrosis-4 scores. CONCLUSION:Individuals with NAFLD have lower peak-stimulated GH levels but similar IGF-1 levels as compared to controls. Higher peak-stimulated GH levels are associated with lower IHL and less hepatocellular damage. Higher IGF-1 levels are associated with more favorable fibrosis risk scores. These data implicate GH and IGF-1 as potential disease modifiers in the development and progression of NAFLD.
PMCID:9387707
PMID: 35779256
ISSN: 1945-7197
CID: 5601922